GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Daniel Bendheim Appointed CEO and President of Phibro Animal Health
Reports Third Quarter Results, Updates Financial Guidance
Declares Quarterly Dividend
Phibro Animal Health Corporation Increases Credit Facility by $125 Million
Announces Regulatory Framework Change in Brazil for Antimicrobials
Director Resignation - Joyce J. Lee Steps Down from Board
Financial Results, Press Release
Other Events
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
Effectiveness Notice
Registration of Securities
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Confidential Treatment Order
Submission Upload